Salvage treatment strategies for recurrence after radical prostatectomy: Current status, challenges, and future directions.

Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42705104

Kunhao Liu; Leijie Wang; Linjie Wu; Peng Zhang; Wang Ye; Ying Yu; Zhongqiang Guo

Sep 8, 2026